Impact of COPD exacerbations on patient-centered outcomes.

BACKGROUND Frequent exacerbations are associated with a faster decline in FEV(1), impaired health status, and worse survival. Their impact and temporal relationship with other outcomes such as functional status, dyspnea, and the multidimensional body mass index, obstruction, dyspnea, exercise capacity (BODE) index remain unknown. HYPOTHESIS We reasoned that exacerbations affect the BODE index and its components, and that changes in the BODE index could be used to monitor the effect of exacerbations on the host. STUDY DESIGN Prospective observational study in a Veterans Affairs medical center. METHODS We studied 205 patients with COPD (mean [+/- SD] FEV(1), 43 +/- 15% predicted), and recorded the body mass index, FEV(1) percent predicted, modified Medical Research Council dyspnea scale, 6-min walk distance, and the BODE index at baseline, during the exacerbation, and at 6, 12, and 24 months following the first episode, and documented all exacerbations for 2 years after the first acute exacerbation. RESULTS From the cohort, 130 patients (63%) experienced 352 exacerbations or (0.85 exacerbations per patient per year); 48 patients (23%), experienced one episode, 82 patients (40%) experienced 2 or more exacerbations, and 50 patients required hospitalization. At study entry, exacerbators had a worse mean baseline BODE index score (4.2 +/- 2.1 vs 3.57 +/- 2.3, respectively; p < 0.03). The BODE index score worsened by 1.38 points during the exacerbation, and remained 0.8 and 1.1 points above baseline at 1 and 2 years, respectively. There was little change in BODE index score at 2 years in nonexacerbators. CONCLUSION COPD exacerbations negatively impact on the BODE index and its components. The BODE index is a sensitive tool used to assess the impact of exacerbations and to monitor COPD disease progression.

[1]  N. Roche,et al.  Effet de la chirurgie de réduction de volume : l’index BODE a une valeur pronostique , 2007 .

[2]  S. Imfeld,et al.  The BODE index after lung volume reduction surgery correlates with survival. , 2006, Chest.

[3]  B. Celli.  Change in the BODE index reflects disease modification in COPD: lessons from lung volume reduction surgery. , 2006, Chest.

[4]  Arul Earnest,et al.  A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. , 2005, Chest.

[5]  B. Celli,et al.  Pulmonary rehabilitation and the BODE index in COPD , 2005, European Respiratory Journal.

[6]  E. Pehlivan,et al.  Factors affecting survival of hospitalised patients with COPD , 2005, European Respiratory Journal.

[7]  M. Martínez-García,et al.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease , 2005, Thorax.

[8]  Thierry Troosters,et al.  Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality – a systematic review , 2005, Respiratory research.

[9]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[10]  Ciro Casanova,et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[11]  B. Celli,et al.  The 6‐min walk distance: change over time and value as a predictor of survival in severe COPD , 2004, European Respiratory Journal.

[12]  N. Anthonisen,et al.  Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2003 .

[13]  G. Diette,et al.  In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. , 2003, Archives of internal medicine.

[14]  J. Wedzicha,et al.  Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[15]  Andrew J. White,et al.  Chronic obstructive pulmonary disease • 6: The aetiology of exacerbations of chronic obstructive pulmonary disease , 2003, Thorax.

[16]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[17]  T. Seemungal,et al.  Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations , 2002, Thorax.

[18]  P. Vermeire,et al.  The burden of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.

[19]  Ramon Gisbert,et al.  Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. , 2002, Chest.

[20]  S. Quintana,et al.  Mortality after hospitalization for COPD. , 2002, Chest.

[21]  Toru Oga,et al.  Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. , 2002, Chest.

[22]  E Monsó,et al.  Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. , 2001, American journal of respiratory and critical care medicine.

[23]  N. Anthonisen,et al.  Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. , 2001, American journal of respiratory and critical care medicine.

[24]  R. Stockley,et al.  Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. , 2001, The European respiratory journal.

[25]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[26]  K. Wright,et al.  Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[27]  S. Sullivan,et al.  The costs of treating COPD in the United States. , 2001, Chest.

[28]  M. Malesker,et al.  Pharmacoeconomic evaluation of COPD. , 2000, Chest.

[29]  T. Seemungal,et al.  Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels , 2000, Thrombosis and Haemostasis.

[30]  R. Rodríguez-Roisín,et al.  Toward a consensus definition for COPD exacerbations. , 2000, Chest.

[31]  T. Seemungal,et al.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.

[32]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[33]  E. Wouters,et al.  Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease , 1998 .

[34]  Alan D. Lopez,et al.  Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.

[35]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[36]  R. Zuwallack,et al.  Variables related to increased mortality following out-patient pulmonary rehabilitation. , 1996, The European respiratory journal.

[37]  J. Gold,et al.  Validation of a combined comorbidity index. , 1994, Journal of clinical epidemiology.

[38]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[39]  C K Wells,et al.  Evaluation of clinical methods for rating dyspnea. , 1988, Chest.

[40]  N. Anthonisen,et al.  Prognosis in chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.